Journey Medical Corporation Annual report pursuant to Section 13 and 15(d)

INTEREST EXPENSE AND FINANCING FEES (Tables)

12 Months Ended

Dec. 31, 2021


	Year Ended December 31,
	2021						2020
($in thousands)	Interest		Fees¹		Total		Interest		Fees¹		Total
Convertible preferred shares	$	2,845	$	2,572	$	5,417	$	—	$	—	$	—
Dividend payable		820		—		820		—		—		—
Installment payments - licenses 2		724		—		724		696		—		696
Anti-itch product installment payments		57		—		57		2		—		2
LOC fees		16				16		—		—		—
Total Interest Expense and Financing Fee	$	4,462	$	2,572	$	7,034	$	698	$	—	$	698

Note 1:Amortization of fees in connection with debt raises.

Note 2: Imputed interest expense related to Ximino, Accutane and anti-itch cream acquisitions.